Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Absci Corporation Common Stock (ABSI)

Services-commercial Physical & Biological Research

https://www.absci.com

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

18105 SE MILL PLAIN BLVD
VANCOUVER, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/22/2021

Market Cap

457,424,780

Shares Outstanding

92,940,000

Weighted SO

92,938,477

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

RXRX --.--%

AFMD --.--%

SANA --.--%

RLAY --.--%

EXAI --.--%

VECT --.--%

ZURA --.--%

ELEV --.--%

ICVX --.--%

Beta

2.2220

Last Div

0.0000

Range

1.111-6.72

Chg

-0.0950

Avg Vol

1634958

Mkt Cap

457424780

Exch

NASDAQ

Country

US

Phone

360 949 1041

DCF Diff

5.7769

DCF

-1.6369

Div Yield

0.0000

P/S

140.7461

EV Multiple

-4.9921

P/FV

2.0625

Div Yield %

0.0000

P/E

-4.9512

PEG

-0.1654

Payout

0.0000

Current Ratio

6.4863

Quick Ratio

6.4863

Cash Ratio

2.3342

DSO

4.9415

DIO

0.0000

Op Cycle

4.9415

DPO

44.8148

CCC

-39.8733

Gross Margin

-3.2452

Op Margin

-30.0803

Pretax Margin

-28.3600

Net Margin

-28.3889

Eff Tax Rate

-0.2695

ROA

-0.3611

ROE

-0.4424

ROCE

-0.4249

NI/EBT

1.0010

EBT/EBIT

0.9428

EBIT/Rev

-30.0803

Debt Ratio

0.0316

D/E

0.0364

LT Debt/Cap

0.0139

Total Debt/Cap

0.0352

Int Coverage

-212.9869

CF/Debt

-7.4345

Equity Multi

1.1537

Rec Turnover

73.8636

Pay Turnover

8.1446

Inv Turnover

0.0000

FA Turnover

0.0792

Asset Turnover

0.0127

OCF/Share

-0.5312

FCF/Share

-0.5370

Cash/Share

1.4323

OCF/Sales

-18.4582

FCF/OCF

1.0110

CF Coverage

-7.4345

ST Coverage

-12.1239

CapEx Coverage

-91.3075

Div&CapEx Cov

-91.3075

P/BV

2.0625

P/B

2.0625

P/S

140.7461

P/E

-4.9512

P/FCF

-7.5425

P/OCF

-7.6150

P/CF

-7.6150

PEG

-0.1654

P/S

140.7461

EV Multiple

-4.9921

P/FV

2.0625

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 10, 07:30 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors Benzinga Jan 08, 14:01 Cracking The Code: Understanding Analyst Reviews For Absci GlobeNewswire Inc. Dec 20, 07:30 Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline GlobeNewswire Inc. Dec 04, 07:30 Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate GlobeNewswire Inc. Nov 14, 02:05 Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases GlobeNewswire Inc. Nov 14, 02:05 Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases GlobeNewswire Inc. Nov 14, 02:05 Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

Revenue Product Segmentation